$NBIO - Nascent Biotech Granted Japanese Patent fo
Post# of 103030
The patent allowance recognizes PTB's ability to act as a monotherapy, as well as its potential to act as a conjugate, bringing other therapies across the BBB.
https://finance.yahoo.com/news/nascent-biotec...00461.html